Remédio para diabetes e obesidade pode elevar risco de cegueira rara

[{"selector":"#anim-e15eb104-8908-4e07-ad26-f40313655aed","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-fc57b496-fc3f-47c0-9941-74d4e4d254ff","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-a92d3182-1ac2-4b00-8900-f8e2304403b7","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-f06a87b5-c401-4c0a-b68f-21c0430dfdb1","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Pavel Danilyuk/Pexels

[{"selector":"#anim-a276e3ec-b168-47c1-a9b5-1793d9eaee20","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6289559e-aceb-49c4-b1ff-a0f0ba4a1aed","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-a2b9e651-f5d1-4a16-9846-47557f04509c","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] [{"selector":"#anim-12aaaae4-4a68-4fbb-aa91-9a3cc1491ecb","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] Pessoas que tomam Ozempic (foto) ou Wegovy podem ter um risco maior de desenvolver uma forma rara de cegueira , sugere um novo estudo Carolina Rudah/GettyImages

[{"selector":"#anim-be77a5e5-44c0-4304-8ea6-2f1406361393","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-5c3b5e40-ab90-4ffc-9910-9b86621e4ffe","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-19fdd825-cb86-4e8c-8cae-13f98e8c97fe","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-5ad82617-6111-4c1d-9f34-3d9657ff3e4f","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Ainda assim, os médicos dizem que isso não deve impedir os pacientes de usar esses medicamentos para tratar diabetes ou obesidade Imyskin/Getty Images

[{"selector":"#anim-fe63dc6b-d6da-4c00-b4ec-fd3f9aaedb5a","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a944c7e3-6c1d-468e-96d8-c14e6399b12d","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-dfb2c82b-917c-40e3-a9f3-79f946ea1b4d","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-50f1d524-4243-4b82-8cad-05b55437d74e","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] No verão passado, médicos do Mass Eye and Ear notaram um número incomumente alto de pacientes com neuropatia óptica isquêmica anterior não arterítica , ou NOIA-NA, um tipo de AVC ocular que causa perda súbita e indolor da visão em um olho Lucas Vinicius/Pexels

[{"selector":"#anim-08e00f9e-a92d-4643-8e71-bf731347996e","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-90139fb6-8463-4800-8e8c-ba48f66d1d39","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-2f55e1fe-4573-4808-a79c-10af78ded6d5","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-c6a39063-63cb-4019-bf55-0c6c062f78a1","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] A condição é relativamente rara — até 10 em 100 mil pessoas na população geral podem experimentá-la —, mas os médicos observaram três casos em uma semana, e cada um desses pacientes estava tomando medicamentos à base de semaglutida The masked Guy/Pexels

[{"selector":"#anim-f9928a6b-1691-4672-b579-e12b835c1c2e","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b98b5b6f-5461-4363-9308-366e459dfd70","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-fbb52937-37b0-43f0-acc2-0ef58bed3bdf","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-88989552-3e91-4b9b-b8a4-128856afc45a","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Uma análise de seis anos de registros médicos mostrou que pessoas com diabetes tinham mais de quatro vezes mais probabilidade de serem diagnosticadas com NOIA-NA se estivessem tomando uma prescrição de semaglutida Maskot/GettyImages

[{"selector":"#anim-9a609326-3dd4-463e-ad67-b4eb40369ce3","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-4e389912-3119-4ba0-92f3-a330ad42f2d2","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-9d91c19e-bfc6-470a-9d85-fdc93609ab67","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-e745f684-ea77-44a9-a119-68528092f602","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] As pessoas com sobrepeso ou obesidade tinham mais de sete vezes mais probabilidade de experimentar a condição se estivessem tomando o medicamento Freepick

[{"selector":"#anim-adc34a79-a6eb-4ede-9cdd-277eb1f69325","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e58ebfc5-274f-4195-bd05-32507a6a56c8","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1b043577-392b-4d91-a6ca-c8d9adf18386","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-4dfef655-5e70-4503-ac77-d75ea5c4aca6","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Especialistas concordam que o risco potencial de NOIA-NA não deve impedir o uso de medicamentos à base de semaglutida para tratar diabetes ou obesidade Michael Siluk/UCG/Universal Images Group/GettyImages

[{"selector":"#anim-041771f8-3949-4476-bbf0-6105e80be9a2","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-e5ce0c27-9e1e-440a-b431-6ce64c46a3ab","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cf94db6c-6972-4855-890d-86699897596f","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-dfb2f7c0-824e-45bf-a03b-8c270be3380c","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Por enquanto, os pacientes que estão tomando semaglutida ou considerando o tratamento devem discutir os riscos e benefícios com seus médicos, especialmente aqueles que têm outros problemas conhecidos no nervo óptico IUULIA BURMISTROVA/GETTY IMAGES

CNNBRASIL.COM.BR

[{"selector":"#anim-036b31fd-0f4e-4467-972d-a47e13d99f28","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-6422aa7c-dfdb-4032-a205-62401743c539","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-595f27b2-7115-46bc-af1e-4e758d93febd","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a1539ea6-ac8c-46dc-ba9e-ad5339138c95","keyframes":{"transform":["translate3d(0px, 2132.63615%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-99fac87e-ebfb-436f-a17b-2822779c1e6a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-43411713-42a6-4bb4-90ee-8a93917c7b05","keyframes":{"transform":["translate3d(-117.84387%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8696721e-cc24-4e38-b631-6fb3bd8ee7a6","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d9f205a5-460c-4d4d-9816-7e4b07f6126f","keyframes":{"transform":["translate3d(0px, 843.84322%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] Freepick leia mais em